New drug for patients with severe COPD
A new drug has been approved for use in England and Wales in patients with severe chronic obstructive pulmonary disease (COPD) who continue to suffer with exacerbations.
The National Institute for Health and Care Excellence (NICE) has this week recommended treatment with roflumilast (Daxas) as an add-on to bronchodilator therapy under certain circumstances. It has been recommended as an option for treating severe COPD in adults with chronic bronchitis, but only under certain circumstances. For further details Nursing Times